A detailed history of Thrivent Financial For Lutherans transactions in Pfizer Inc stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 719,096 shares of PFE stock, worth $20.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
719,096
Previous 2,447,704 70.62%
Holding current value
$20.1 Million
Previous $70.5 Million 71.68%
% of portfolio
0.04%
Previous 0.15%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $44.8 Million - $51.4 Million
-1,728,608 Reduced 70.62%
719,096 $20 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $14.9 Million - $19.4 Million
-571,494 Reduced 18.93%
2,447,704 $70.5 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $4.75 Million - $5.55 Million
147,977 Added 5.15%
3,019,198 $100 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $4.63 Million - $5.36 Million
128,204 Added 4.67%
2,871,221 $105 Million
Q1 2023

May 17, 2023

SELL
$39.39 - $51.28 $50.3 Million - $65.5 Million
-1,277,046 Reduced 31.77%
2,743,017 $112 Million
Q4 2022

Feb 08, 2023

BUY
$41.75 - $54.5 $89.9 Million - $117 Million
2,153,070 Added 115.32%
4,020,063 $206 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $62.2 Million - $76 Million
1,421,952 Added 319.51%
1,866,993 $81.7 Million
Q2 2022

Aug 16, 2022

SELL
$46.53 - $55.17 $5.65 Million - $6.7 Million
-121,469 Reduced 21.44%
445,041 $23.3 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $5.74 Million - $7.12 Million
125,526 Added 28.46%
566,510 $29.8 Million
Q4 2021

Feb 16, 2022

SELL
$41.32 - $61.25 $41,278 - $61,188
-999 Reduced 0.23%
440,984 $22 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $2.79 Million - $3.59 Million
-71,179 Reduced 13.87%
441,983 $18.8 Million
Q2 2021

Sep 24, 2021

BUY
$35.91 - $40.68 $4.87 Million - $5.52 Million
135,609 Added 35.92%
513,162 $20.1 Million
Q2 2021

Aug 19, 2021

SELL
$35.91 - $40.68 $4.81 Million - $5.45 Million
-133,911 Reduced 26.18%
377,553 $14.8 Million
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $1.13 Million - $1.27 Million
-33,746 Reduced 6.19%
511,464 $18.5 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $178,595 - $227,100
-5,336 Reduced 0.97%
545,210 $20.1 Million
Q3 2020

Nov 10, 2020

SELL
$31.75 - $37.25 $4.51 Million - $5.29 Million
-142,075 Reduced 20.51%
550,546 $20.2 Million
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $38.7 Million - $47 Million
-1,285,580 Reduced 64.99%
692,621 $22.5 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $5.51 Million - $7.87 Million
-203,876 Reduced 9.34%
1,978,201 $64.5 Million
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $2.61 Million - $2.96 Million
79,251 Added 3.77%
2,182,077 $85.5 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $40.6 Million - $52.6 Million
-1,249,099 Reduced 37.27%
2,102,826 $75.6 Million
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $5.97 Million - $6.7 Million
161,374 Added 5.06%
3,351,925 $145 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $23.6 Million - $25.9 Million
-628,515 Reduced 16.46%
3,190,551 $136 Million
Q4 2018

Feb 15, 2019

SELL
$38.47 - $43.86 $3.65 Million - $4.16 Million
-94,811 Reduced 2.42%
3,819,066 $167 Million
Q3 2018

Nov 15, 2018

SELL
$34.47 - $41.81 $213,507 - $258,971
-6,194 Reduced 0.16%
3,913,877 $172 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $9.01 Million - $9.61 Million
-273,276 Reduced 6.52%
3,920,071 $142 Million
Q1 2018

May 08, 2018

BUY
$31.91 - $37.02 $3.49 Million - $4.05 Million
109,378 Added 2.68%
4,193,347 $149 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $1.4 Million - $1.48 Million
41,976 Added 1.04%
4,083,969 $148 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $125 Million - $138 Million
4,041,993
4,041,993 $144 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.